Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. | Inflamm Res;54(11): 464-70, 2005 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.

Liu, D; Zeng, B X; Zhang, S H; Yao, S L.

Affiliation

Liu D; Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. dongliu67@yahoo.com.cn

Inflamm Res ; 54(11): 464-70, 2005 Nov.

Article in En | MEDLINE | ID: mdl-16307220

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Endotoxemia / Thiazolidinediones / PPAR gamma / Lung / Anti-Inflammatory Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Inflamm Res Journal subject: ALERGIA E IMUNOLOGIA / PATOLOGIA Year: 2005 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Endotoxemia / Thiazolidinediones / PPAR gamma / Lung / Anti-Inflammatory Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Inflamm Res Journal subject: ALERGIA E IMUNOLOGIA / PATOLOGIA Year: 2005 Document type: Article Affiliation country: Country of publication: